These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients. Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505 [TBL] [Abstract][Full Text] [Related]
31. [Prognostic value of elevation of plasma concentration of atrial natriuretic peptide in patients with cardiac failure. Results of a cohort study]. Vizir VA; Berezin AE Klin Med (Mosk); 2003; 81(11):24-30. PubMed ID: 14689705 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Tsutamoto T; Hisanaga T; Fukai D; Wada A; Maeda Y; Maeda K; Kinoshita M Am J Cardiol; 1995 Oct; 76(11):803-8. PubMed ID: 7572659 [TBL] [Abstract][Full Text] [Related]
33. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin. Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL; Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795 [TBL] [Abstract][Full Text] [Related]
35. Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure. Tsutamoto T; Wada A; Hisanaga T; Maeda K; Ohnishi M; Mabuchi N; Sawaki M; Hayashi M; Fujii M; Kinoshita M J Am Coll Cardiol; 1999 Feb; 33(2):530-7. PubMed ID: 9973035 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. Tsutamoto T; Hisanaga T; Wada A; Maeda K; Ohnishi M; Fukai D; Mabuchi N; Sawaki M; Kinoshita M J Am Coll Cardiol; 1998 Feb; 31(2):391-8. PubMed ID: 9462584 [TBL] [Abstract][Full Text] [Related]
37. Plasma levels of endothelin-1 at rest and after exercise in patients with moderate congestive heart failure. de Groote P; Millaire A; Racadot A; Decoulx E; Ducloux G Int J Cardiol; 1995 Oct; 51(3):267-72. PubMed ID: 8586475 [TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group. Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344 [TBL] [Abstract][Full Text] [Related]
39. The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure. Pan JP; Liu TY; Chiang SC; Lin YK; Chou CY; Chan WL; Lai ST J Chin Med Assoc; 2004 May; 67(5):222-8. PubMed ID: 15357108 [TBL] [Abstract][Full Text] [Related]
40. Renal endothelin in heart failure and its relation to sodium excretion. Modesti PA; Cecioni I; Costoli A; Poggesi L; Galanti G; Serneri GG Am Heart J; 2000 Oct; 140(4):617-22. PubMed ID: 11011335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]